Rockefeller Capital Management’s Definium Therapeutics DFTX Stock Holding History

Rockefeller Capital Management’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.3M	Buy	70,111 +14,905	+27%	+$368K	0.01%	1158
2026 Q1	$1.04M	Buy	55,206 +54,855	+15,628%	+$931K	﹤0.01%	1591
2025 Q4	$4.7K	Hold	351	–	–	﹤0.01%	4089
2025 Q3	$4.14K	Buy	+351	New	+$3.27K	﹤0.01%	3927
2023 Q1	–	Sell	-148	Closed	–	–	3149
2022 Q4	$0	Hold	148	–	–	﹤0.01%	4075
2022 Q3	$0	Sell	148 -1	-0.7%	-$10	﹤0.01%	4192
2022 Q2	$1K	Hold	149	–	–	﹤0.01%	3985
2022 Q1	$2K	Hold	149	–	–	﹤0.01%	3623
2021 Q4	$3K	Hold	149	–	–	﹤0.01%	3445
2021 Q3	$5K	Sell	149 -10	-6%	-$432	﹤0.01%	3177
2021 Q2	$8K	Buy	+159	New	+$8.35K	﹤0.01%	2877

Other funds holding DFTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Rockefeller Capital Management's DFTX Position: Q2 2026 in Review

Rockefeller Capital Management increased its Definium Therapeutics (DFTX) stake by 27% in Q2 2026, buying an estimated $368K and bringing the position to 70,111 shares worth $3.3M. The position accounts for 0.01% of the portfolio, ranked #1158.

Rockefeller Capital Management first reported a position in DFTX in Q2 2021 and has held it in 11 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

Rockefeller Capital Management held 70,111 shares of Definium Therapeutics worth $3.3M as of Q2 2026.
Rockefeller Capital Management bought 14,905 Definium Therapeutics shares in Q2 2026, an estimated $368K.
Definium Therapeutics made up 0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #1158 holding.
Rockefeller Capital Management first reported a position in Definium Therapeutics in Q2 2021 and has held it in 11 quarters since.
362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.